September 01, 2017


 Phi Zeta presents research awards

Posted Aug. 16, 2017

Phi Zeta, the international honor society of veterinary medicine, recently presented awards to authors of two research manuscripts among submissions from the Phi Zeta chapters at 28 U.S. and two Caribbean veterinary colleges. Established in 1978, the awards consist of a plaque and a $1,000 check.

Dr. Li Dr. Lundberg
Dr. Ronald Li Dr. Alycen Lundberg

The basic sciences award went to Dr. Ronald Li (Guelph '09) at the Lambda chapter of Phi Zeta at the University of California-Davis. His winning paper was "Platelet activation and clopidogrel effects on ADP-induced platelet activation in cats with or without the A31P mutation in MYBPC3" (J Vet Intern Med 2016;30:1619-1629).

Dr. Li is a doctoral candidate and Morris Animal Foundation Research Fellow at UC-Davis. After a rotating internship in Toronto, he pursued an emergency and critical care residency and in 2011 earned a Master of Veterinary Medicine degree at the University of London Royal Veterinary College. He became a diplomate of the American College of Veterinary Emergency and Critical Care in 2014. Dr. Li's research focuses on platelet signaling, thrombosis, and neutrophil biology in sepsis. His clinical interests are management of respiratory failure, acquired coagulopathy, and thrombosis in critical illness.

The clinical sciences award was presented to Dr. Alycen Lundberg (Minnesota '12) at the Mu chapter of Phi Zeta at the University of Illinois. Her winning paper was "Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-dexoynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species" (Invest New Drugs 2017;35:134-144).

Dr. Lundberg completed a small animal rotating internship at Iowa State University in 2013 and a medical oncology residency at the University of Illinois at Urbana-Champaign in 2016. She stayed at Illinois as a doctoral candidate in the Comparative Oncology Research Laboratory, with her research focusing on targeted anti-cancer therapies in dogs and cats. She also spends time as a clinical instructor in the medical oncology service.​